 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Aptorum Group Limited
APM
|
105 |
$ 0.82 |
-3.48 % |
$ 4.47 M |
China |
 |
Rigel Pharmaceuticals
RIGL
|
2.03 |
$ 33.23 |
-4.03 % |
$ 584 M |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Acer Therapeutics
ACER
|
25.8 |
- |
2.71 % |
$ 14 M |
USA |
 |
Ampio Pharmaceuticals
AMPE
|
106 |
- |
-11.43 % |
$ 502 K |
USA |
 |
Apellis Pharmaceuticals
APLS
|
2.76 |
$ 20.15 |
-2.68 % |
$ 2.54 B |
USA |
 |
AbCellera Biologics
ABCL
|
12.8 |
$ 3.72 |
-2.75 % |
$ 1.11 B |
Canada |
 |
Athersys
ATHX
|
253 |
- |
3.77 % |
$ 22.4 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
AVEO Pharmaceuticals
AVEO
|
2.32 |
- |
- |
$ 521 M |
USA |
 |
Axsome Therapeutics
AXSM
|
13.6 |
$ 163.7 |
-1.61 % |
$ 8.14 B |
USA |
 |
BridgeBio Pharma
BBIO
|
26.1 |
$ 64.66 |
-1.37 % |
$ 12.4 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Burford Capital Limited
BUR
|
6.35 |
$ 8.52 |
-2.46 % |
$ 1.39 B |
Britain |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
CymaBay Therapeutics
CBAY
|
110 |
- |
- |
$ 3.45 B |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Avid Bioservices
CDMO
|
3.03 |
- |
- |
$ 789 M |
USA |
 |
Certara
CERT
|
2.57 |
$ 7.16 |
1.49 % |
$ 1.15 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
3.91 K |
- |
- |
$ 169 M |
USA |
 |
Caladrius Biosciences
CLBS
|
3.58 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Alpine Immune Sciences
ALPN
|
8.94 |
- |
- |
$ 2.17 B |
USA |
 |
Clovis Oncology
CLVS
|
1.55 |
- |
-7.23 % |
$ 13 M |
USA |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Capricor Therapeutics
CAPR
|
6.17 |
$ 25.91 |
-3.56 % |
$ 694 M |
USA |
 |
Catalyst Pharmaceuticals
CPRX
|
5.16 |
$ 24.0 |
0.5 % |
$ 2.93 B |
USA |
 |
Acasti Pharma
ACST
|
0.203 |
- |
4.01 % |
$ 150 M |
Canada |
 |
Codexis
CDXS
|
4.91 |
$ 0.99 |
-3.28 % |
$ 72.7 M |
USA |
 |
CTI BioPharma Corp.
CTIC
|
10.2 |
- |
- |
$ 1.2 B |
USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
130 |
- |
-5.98 % |
$ 34.1 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
2.54 K |
- |
-4.36 % |
$ 27 M |
USA |
 |
Deciphera Pharmaceuticals
DCPH
|
7.34 |
- |
- |
$ 2.18 B |
USA |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Denali Therapeutics
DNLI
|
7.68 |
$ 20.02 |
-4.67 % |
$ 3.29 B |
USA |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Eton Pharmaceuticals
ETON
|
3.61 |
$ 17.54 |
-3.36 % |
$ 450 M |
USA |
 |
Entasis Therapeutics Holdings
ETTX
|
9.91 |
- |
- |
$ 105 M |
USA |
 |
Evofem Biosciences
EVFM
|
0.212 |
- |
7.55 % |
$ 38.1 M |
USA |